Lantheus Holdings Inc (NASDAQ:LNTH)
| 21.71 Delayed Data As of Apr 16 |  -0.09 / -0.41%Today’s Change | 10.52 Today|||52-Week Range 21.99 | +60.93% Year-to-Date |
Latest LNTH News | Press Releases
No recent news for Lantheus Holdings Inc.
Today’s Trading
| Previous close | 21.80 |
| Today’s open | 21.55 |
| Day’s range | 21.55 - 21.97 |
| Volume | 17,579 |
| Average volume (3 months) | 563,680 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 04/16/2021
Growth & Valuation
| Earnings growth (last year) | -130.65% |
| Earnings growth (this year) | -21.81% |
| Earnings growth (next 5 years) | +34.00% |
| Revenue growth (last year) | -2.28% |
| P/E ratio | NM |
| Price/Sales | 2.15 |
| Price/Book | 2.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRILTrillium Therapeutic... | -0.43 | -4.14% |
| VIVOMeridian Bioscience ... | -0.37 | -1.57% |
| CLDXCelldex Therapeutics... | +0.02 | +0.08% |
| MYGNMyriad Genetics Inc | -1.43 | -4.97% |
Data as of 3:59pm ET, 04/16/2021
Financials
| Next reporting date | May 4, 2021 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $339.4M |
| Annual profit (last year) | -$13.5M |
| Net profit margin | -3.97% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters North Billerica, Massachusetts |
Forecasts
